Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03879694
Title Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

pulmonary neuroendocrine tumor

gastrointestinal neuroendocrine tumor

pancreatic endocrine carcinoma

Therapies

Octreotide + Sargramostim + SurVaxM

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field